Valuation: Almirall, S.A.

Market Cap 2.27B 2.61B 2.15B 1.95B 3.65B 250B 3.66B 25.66B 9.92B 127B 9.8B 9.59B 409B P/E 2026 *
26.9x
P/E 2027 * 19.3x
Enterprise Value 2.18B 2.5B 2.06B 1.87B 3.5B 240B 3.51B 24.58B 9.5B 122B 9.39B 9.18B 392B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.52x
Free-Float
35.93%
Yield 2026 *
1.94%
Yield 2027 * 2.01%
1 day-1.51%
1 week+2.35%
Current month+1.16%
1 month+0.58%
3 months-6.12%
6 months-6.79%
Current year-18.69%
1 week 10.18
Extreme 10.18
10.82
1 month 10.02
Extreme 10.02
10.82
Current year 10.02
Extreme 10.02
13.98
1 year 10.02
Extreme 10.02
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
14.5
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 2022-11-01
Director of Finance/CFO 53 2025-08-30
Chief Tech/Sci/R&D Officer - 2021-07-06
Director TitleAgeSince
Director/Board Member - 2013-12-31
Director/Board Member - 2015-12-31
Chairman - 2022-05-05
Date Insider Type Main position Quantity % Market Cap. Importance
6/23/23 Buy

Executive/Senior Manager

3,000 0.0017%
6/22/23 Buy 4,340 0.0024%
6/22/23 Buy

Executive/Senior Manager

5,000 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
-1.51%+2.35%-8.90%+5.03% 2.61B
+0.04%+3.34%+53.32%+100.52% 1,028B
-0.09%+1.66%+53.24%+66.45% 651B
-0.02%+2.66%+18.65%+71.97% 466B
-1.22%+3.66%+34.59%+38.81% 346B
-0.79%+2.73%+17.73%+25.11% 266B
+0.58%+6.76%+10.58%+17.75% 259B
+1.55%+2.20%+35.12%+45.91% 208B
+0.79%+1.84%-27.55%-56.48% 191B
-0.52%+4.45%+31.57%+98.11% 186B
Average -0.12%+3.16%+21.83%+41.32% 360.43B
Weighted average by Cap. -0.04%+3.09%+34.81%+61.56%

Financials

2026 *2027 *
Net sales 1.23B 1.41B 1.16B 1.05B 1.97B 135B 1.98B 13.86B 5.36B 68.76B 5.29B 5.18B 221B 1.35B 1.55B 1.28B 1.16B 2.17B 149B 2.18B 15.25B 5.89B 75.64B 5.82B 5.7B 243B
Net income 82.4M 94.58M 77.78M 70.62M 132M 9.07B 133M 930M 359M 4.61B 355M 348M 14.83B 115M 132M 108M 98.39M 184M 12.64B 185M 1.3B 501M 6.43B 495M 484M 20.65B
Net Debt -96.28M -111M -90.88M -82.52M -155M -10.6B -155M -1.09B -420M -5.39B -415M -406M -17.32B -227M -261M -214M -195M -365M -25.01B -366M -2.56B -991M -12.72B -979M -958M -40.86B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,097
Date Price Change Volume
26-09-18 €10.44 -1.51% 253,178
26-09-17 €10.60 -0.75% 124,872
26-09-16 €10.68 +1.33% 146,048
26-09-15 €10.54 +2.73% 292,093
26-09-14 €10.26 +0.59% 104,673
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
10.44EUR
Average target price
14.32EUR
Spread / Average Target
+37.21%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!